Abstract
The discovery of CB1 and CB2 receptors and of endogenous agonists for these receptors has sparked renewed interest in the therapeutic potential of cannabinoids. This has led to a need for strategies that will provide a better separation of wanted from unwanted effects, particularly for CB1 receptor agonists. Possible strategies are to target CB1 receptors present on neurones outside the central nervous system or novel types or subtypes of neuronal cannabinoid receptor. This paper reviews evidence for the presence of CB1 receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors.
Original language | English |
---|---|
Pages (from-to) | 597-605 |
Number of pages | 9 |
Journal | Life Sciences |
Volume | 65 |
Publication status | Published - 1999 |
Keywords
- peripheral cannabinoid CB1 receptors
- CB2-like receptors
- AM630
- guinea-pig small intestine
- mouse vas deferens
- palmitoylethanolamide
- PIG SMALL-INTESTINE
- ELECTRICALLY-EVOKED CONTRACTIONS
- MOUSE VAS-DEFERENS
- RAT-BRAIN
- MYENTERIC PLEXUS
- SELECTIVE ANTAGONIST
- BINDING
- ANANDAMIDE
- AGONISTS
- INHIBITION